TargetBeta
IL4R
interleukin 4 receptor · also CD124 · CD molecules
4 programs in company-led studies act on IL4R, from 3 companies: 3 in phase 3, 1 approved with new studies. Each with where its target was read from.
Programs
Furthest phase first. A target read by rule is marked rule (1 of them); the others are the company’s own words or a reading by Claude, each quoted on the program’s page.
| Program | Company | Furthest phase | Studies | Also acts on | Read from |
|---|---|---|---|---|---|
| dupilumabrule | Sanofi | phase 4 | 9314 running | – | ChEMBL |
| drotokibart | Jiangsu HengRui Medicine | phase 3 | 84 running | – | the company's pipeline |
| TQH2722 | Sino Biopharmaceutical | phase 3 | 71 running | – | the company's pipeline |
| SHR-1819 | Jiangsu HengRui Medicine | phase 3 | 51 running | – | the company's pipeline |
Conditions their studies are in
- Dermatitis, Atopic, 4 programs
- Asthma, 2 programs
- Rhinitis, Allergic, Seasonal, 2 programs
- Eosinophilic Esophagitis, 1 program
- Nasal Polyps, 1 program
- Prurigo, 1 program
- Pulmonary Disease, Chronic Obstructive, 1 program
- Rhinosinusitis, 1 program
- Sinusitis, 1 program
Primary completions ahead
Each program’s next study to reach its primary completion, by the sponsor’s estimate.
- Nov 2026TQH2722 · Sino Biopharmaceutical · phase 3 · NCT07398859
- Dec 2026drotokibart · Jiangsu HengRui Medicine · phase 3 · NCT07688772
- Feb 7, 2027dupilumab · Sanofi · phase 4 · NCT07905547
- Jun 2027SHR-1819 · Jiangsu HengRui Medicine · phase 3 · NCT07321951
What this can’t show
- Only programs whose target has been read: most early programs are named only by a code and their companies do not say what they act on.
- A target read by rule can be wrong; each program’s page quotes the words it was read from.
- “Acts on” does not say how: an agonist and an antagonist of the same receptor are listed together (avexitide blocks the GLP-1 receptor that semaglutide activates).
- Programs in company-led studies on ClinicalTrials.gov with a study in the last two years; academic studies and other registries are not counted here.